health - "develop"

Children vaccinated against hepatitis B probably are not at an increased risk of developing multiple sclerosis unless they were inoculated with a particular brand of the vaccine, according to a new study.

BANGALORE/HONG KONG (Reuters) - When her baby turned blue, Nivetha Biju rushed the child to the emergency room of an Indian hospital and watched helplessly as the baby lost consciousness because the nurses on duty had no idea what to do.

Cancer Research UK, Cancer Research Technology (CRT) - the charity's development and commercialisation arm - and Astex Therapeutics Limited announced today that they have agreed to take into development a potential new anti-cancer treatment.

People with three genetic variants may be at up to 40-fold increased risk of developing gout, a finding that could show who is it at highest risk long before symptoms appear, researchers say.

When her baby turned blue, Nivetha Biju rushed the child to the emergency room of an Indian hospital and watched helplessly as the baby lost consciousness because the nurses on duty had no idea what to do.

LONDON (Reuters) - Women who were bigger and longer babies may be more likely to develop breast cancer, researchers reported on Tuesday.

Pfizer Inc will drop efforts to develop medicines for heart disease, obesity and bone health as part of its plan to focus research on cancer and five other therapeutic areas, a company memo showed.

Researchers have found that youths who take their first drink of alcohol before their 15th birthday are at greater risk of developing alcohol-use disorders as adults.

NPR's 'Morning Edition' on Tuesday reported on the estimated cost of the health care proposal of Democratic presidential nominee Sen. Barack Obama (Ill.). The segment includes comments from Joe Antos, a health policy analyst at the American Enterprise Institute; David Cutler, an economist at Harvard University who helped develop the proposal; and health policy analyst Jeff Goldsmith (Rovner, 'Morning Edition,' NPR, 9/30).read more

Pfizer plans to abandon heart-drug development that they are giving up on the Cardiovascular business and no longer developing compounds in cardiovascular disease, instead focusing on oncology and other areas. This is quite a statement coming from Pfizer, given the long history in cardiovascular disease with block busters in the last ten years such as Norvasc, Caudura, Viagra, Acupril and Lipitor. Pfizer was a CV power house, and they bought Warner Lambert just so they could get even bigger in CV, and now they leave the field. (amazing)read more